Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
28 hedge funds and large institutions have $30.1M invested in Apollo Endosurgery, Inc. in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 5 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
10% less funds holding
Funds holding: 31 → 28 (-3)
12% less capital invested
Capital invested by funds: $34.2M → $30.1M (-$4.06M)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$552K |
| 2 |
GS
Gagnon Securities
New York
|
+$341K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$285K |
| 4 |
BlackRock
New York
|
+$39.9K |
| 5 |
Renaissance Technologies
New York
|
+$12.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$356K |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$212K |
| 3 |
FPC
Falcon Point Capital
San Francisco,
California
|
-$86.3K |
| 4 |
SFS
Strategic Financial Services
Utica,
New York
|
-$51K |
| 5 |
Millennium Management
New York
|
-$45K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RE
26
RBC Europe
London,
United Kingdom
| $3 | – | – | – |
|
|
WVP
27
Worth Venture Partners
Fort Lee,
New Jersey
| – | -$212K | -56,446 | Closed |
|
|
SFS
28
Strategic Financial Services
Utica,
New York
| – | -$51K | -13,600 | Closed |
|
|
29
Millennium Management
New York
| – | -$45K | -12,081 | Closed |
|
30
Bank of America
Charlotte,
North Carolina
| – | -$8K | -2,123 | Closed |
|
31
Barclays
London,
United Kingdom
| – | -$1K | -353 | Closed |
|
32
Morgan Stanley
New York
| – | +$107 | +30 | +600% |
|
APEN Hedge Fund Activity: Q2 2019 in Review
28 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q2 2019, worth a combined $30.1M — down 12% from $34.2M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of APEN and 2 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 7 added.
The largest buyer was Vanguard Group, adding an estimated $552K. The largest seller was Nantahala Capital Management, cutting an estimated $356K.
- 28 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q2 2019, down from 31 in Q1 2019.
- Funds reported $30.1M of Apollo Endosurgery, Inc. stock for Q2 2019, down 12% quarter-over-quarter.
- 2 funds opened new Apollo Endosurgery, Inc. positions in Q2 2019 and 5 closed out, a net change of -3 holders.
- The largest Apollo Endosurgery, Inc. buyer in Q2 2019 was Vanguard Group, an estimated $552K added.
- The largest Apollo Endosurgery, Inc. seller in Q2 2019 was Nantahala Capital Management, an estimated $356K sold.
Based on aggregated 13F filings for Q2 2019.